APM Company Profile and Key Details
Aptorum Group Limited
APM Stock Price Chart
Stock Price Today
Aptorum Group Limited (APM) stock declined over -2.54%, trading at $1.15 on NASDAQ, down from the previous close of $1.18. The stock opened at $1.19, fluctuating between $1.10 and $1.20 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Company Information
| Employees | 3 |
| Beta | 1.3 |
| Sales or Revenue | $1.30M |
| 5Y Sales Change% | -0.306% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Aptorum Group Limited (NASDAQ: APM) stock price is $1.15 in the last trading session. During the trading session, APM stock reached the peak price of $1.20 while $1.10 was the lowest point it dropped to. The percentage change in APM stock occurred in the recent session was -2.54% while the dollar amount for the price change in APM stock was -$0.03.
The NASDAQ listed APM is part of Biotechnology industry that operates in the broader Healthcare sector. Aptorum Group Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Chung Yuen Huen
Founder & Non-Executive Director
Dr. Wai Yip Lee
Head of R&D
Mr. Darren Lui
Chief Executive Officer, Chief Accounting Officer & Executive Director
Mr. Martin Siu
Head of Fin.
Dr. Clark Cheng
Chief Medical Officer & Executive Director
APM's closing price is 150% higher than its 52-week low of $0.46 where as its distance from 52-week high of $17.49 is -93.42%.
Number of APM employees currently stands at 3.
Official Website of APM is: https://www.aptorumgroup.com
APM could be contacted at phone 442 080 929299 and can also be accessed through its website. APM operates from 17 Hanover Square, London, W1S 1BN, United Kingdom.
APM stock volume for the day was 102.96K shares. The average number of APM shares traded daily for last 3 months was 2.34M.
The market value of APM currently stands at $8.22M with its latest stock price at $1.15 and 7.14M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com